Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis

Abstract Introduction Esophageal squamous cell carcinoma (ESCC) represents a major malignancy with poor clinical outcomes. Long noncoding RNAs (lncRNAs) are known to regulate the development and progression of multiple cancers. However, how lncRNAs are involved in ESCC is currently undefined. Method...

Full description

Bibliographic Details
Main Authors: Yuhang Xiao, Jinming Tang, Desong Yang, Baihua Zhang, Jie Wu, Zhining Wu, Qianjin Liao, Hui Wang, Wenxiang Wang, Min Su
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-022-00408-x
_version_ 1798038797773963264
author Yuhang Xiao
Jinming Tang
Desong Yang
Baihua Zhang
Jie Wu
Zhining Wu
Qianjin Liao
Hui Wang
Wenxiang Wang
Min Su
author_facet Yuhang Xiao
Jinming Tang
Desong Yang
Baihua Zhang
Jie Wu
Zhining Wu
Qianjin Liao
Hui Wang
Wenxiang Wang
Min Su
author_sort Yuhang Xiao
collection DOAJ
description Abstract Introduction Esophageal squamous cell carcinoma (ESCC) represents a major malignancy with poor clinical outcomes. Long noncoding RNAs (lncRNAs) are known to regulate the development and progression of multiple cancers. However, how lncRNAs are involved in ESCC is currently undefined. Methods LIPH-4 levels in ESCC tissue specimens and cells were assessed by qRT-PCR. The biological function of LIPH-4 was examined in cell and animal studies, applying CCK-8, EdU, colony formation and flow cytometry assays as well as xenograft model experiments. The underlying mechanisms of action of LIPH-4 were explored through bioinformatics, luciferase reporter assay, RNA-immunoprecipitation assay and immunoblot. Results We identified a novel lncRNA, LIPH-4, which showed elevated amounts in ESCC tissues and positive correlations with increased tumor size and poor prognosis in ESCC patients. Functional studies showed that LIPH-4 promoted the growth, mediated cell cycle progression and inhibited apoptosis in ESCC cells in vitro, and promoted tumor growth in mice. In terms of mechanism, LIPH-4 could bind to miR-216b and act as a competing endogenous RNA (ceRNA) to induce the expression of miR-216’s target gene IGF2BP2. LIPH-4 played an oncogenic role in ESCC through the miR-216b/IGF2BP2 axis. Conclusions This study suggested that LIPH-4 functions as a novel oncogenic lncRNA by acting as a ceRNA for miR-216b to regulate IGF2BP2, indicating LIPH-4 likely constitutes a prognostic biomarker and therapeutic target in ESCC.
first_indexed 2024-04-11T21:45:16Z
format Article
id doaj.art-d1fdd205c12b4bbfb4c35f13fd6d7bf0
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-04-11T21:45:16Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-d1fdd205c12b4bbfb4c35f13fd6d7bf02022-12-22T04:01:26ZengBMCBiomarker Research2050-77712022-08-0110111210.1186/s40364-022-00408-xLong noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axisYuhang Xiao0Jinming Tang1Desong Yang2Baihua Zhang3Jie Wu4Zhining Wu5Qianjin Liao6Hui Wang7Wenxiang Wang8Min Su9Hunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityKey Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityHunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityAbstract Introduction Esophageal squamous cell carcinoma (ESCC) represents a major malignancy with poor clinical outcomes. Long noncoding RNAs (lncRNAs) are known to regulate the development and progression of multiple cancers. However, how lncRNAs are involved in ESCC is currently undefined. Methods LIPH-4 levels in ESCC tissue specimens and cells were assessed by qRT-PCR. The biological function of LIPH-4 was examined in cell and animal studies, applying CCK-8, EdU, colony formation and flow cytometry assays as well as xenograft model experiments. The underlying mechanisms of action of LIPH-4 were explored through bioinformatics, luciferase reporter assay, RNA-immunoprecipitation assay and immunoblot. Results We identified a novel lncRNA, LIPH-4, which showed elevated amounts in ESCC tissues and positive correlations with increased tumor size and poor prognosis in ESCC patients. Functional studies showed that LIPH-4 promoted the growth, mediated cell cycle progression and inhibited apoptosis in ESCC cells in vitro, and promoted tumor growth in mice. In terms of mechanism, LIPH-4 could bind to miR-216b and act as a competing endogenous RNA (ceRNA) to induce the expression of miR-216’s target gene IGF2BP2. LIPH-4 played an oncogenic role in ESCC through the miR-216b/IGF2BP2 axis. Conclusions This study suggested that LIPH-4 functions as a novel oncogenic lncRNA by acting as a ceRNA for miR-216b to regulate IGF2BP2, indicating LIPH-4 likely constitutes a prognostic biomarker and therapeutic target in ESCC.https://doi.org/10.1186/s40364-022-00408-xEsophageal squamous cell carcinomaLong noncoding RNALIPH-4miR-216bIGF2BP2
spellingShingle Yuhang Xiao
Jinming Tang
Desong Yang
Baihua Zhang
Jie Wu
Zhining Wu
Qianjin Liao
Hui Wang
Wenxiang Wang
Min Su
Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
Biomarker Research
Esophageal squamous cell carcinoma
Long noncoding RNA
LIPH-4
miR-216b
IGF2BP2
title Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
title_full Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
title_fullStr Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
title_full_unstemmed Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
title_short Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
title_sort long noncoding rna liph 4 promotes esophageal squamous cell carcinoma progression by regulating the mir 216b igf2bp2 axis
topic Esophageal squamous cell carcinoma
Long noncoding RNA
LIPH-4
miR-216b
IGF2BP2
url https://doi.org/10.1186/s40364-022-00408-x
work_keys_str_mv AT yuhangxiao longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT jinmingtang longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT desongyang longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT baihuazhang longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT jiewu longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT zhiningwu longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT qianjinliao longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT huiwang longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT wenxiangwang longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis
AT minsu longnoncodingrnaliph4promotesesophagealsquamouscellcarcinomaprogressionbyregulatingthemir216bigf2bp2axis